Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEVP & Chairman, PartneringCIK 0001814238
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | Hite ChristopherEVP & Chairman, Partnering |  RPRXRoyalty Pharma plcGrant or award | A | — 7,122 sh | Nov 6, 2026 traded Nov 4, 2026 | |
Hite ChristopherEVP & Chairman, Partnering |
| RPRXRoyalty Pharma plc Open-market sale · 10b5-1 plan |
| SELL |
| $231K 3,927 sh |
| Sep 24, 2026 traded Sep 22, 2026 |
| 23 | Hite ChristopherEVP & Chairman, Partnering | RPRXRoyalty Pharma plc Open-market sale · 10b5-1 plan | SELL | $5.62M 96.1K sh | Sep 24, 2026 traded Sep 22, 2026 |
| 23 | Hite ChristopherEVP & Chairman, Partnering | RPRXRoyalty Pharma plc Open-market sale · 10b5-1 plan | SELL | $6.00M 100.0K sh | Aug 19, 2026 traded Aug 18, 2026 |
| 10 | Hite ChristopherEVP & Chairman, Partnering | RPRXRoyalty Pharma plc Gift · 10b5-1 plan | G | — 16.8K sh | Aug 19, 2026 traded Aug 19, 2026 |
| 5 | Hite ChristopherEVP & Chairman, Partnering | RPRXRoyalty Pharma plc Grant or award | A | — 11.0K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 19 | Hite ChristopherEVP & Chairman, Partnering | RPRXRoyalty Pharma plc Open-market sale · 10b5-1 plan | SELL | $1.75M 32.4K sh | Jun 25, 2026 traded Jun 23, 2026 |
| 23 | Hite ChristopherEVP & Chairman, Partnering | RPRXRoyalty Pharma plc Open-market sale · 10b5-1 plan | SELL | $6.41M 117.6K sh | Jun 25, 2026 traded Jun 23, 2026 |
| 9 | Hite ChristopherEVP & Vice Chairman | RPRXRoyalty Pharma plc Grant or award | A | — 26.6K sh | Feb 13, 2026 traded Feb 11, 2026 |
| 9 | Hite ChristopherEVP & Vice Chairman | RPRXRoyalty Pharma plc Grant or award | A | — 6,168 sh | Nov 7, 2025 traded Nov 5, 2025 |